Sonoma Pharmaceuticals (SNOA) Tax Provisions (2016 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Tax Provisions of $84000.0 for Q1 2026, down 66.13% year-over-year from $248000.0 in Q1 2025, and up 164.62% quarter-over-quarter from -$130000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Tax Provisions (2016 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Tax Provisions history runs 9 years deep, the most recent figure standing at $84000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 66.13% year-over-year to $84000.0; the TTM figure through Mar 2026 stood at -$244000.0 (down 144.36% YoY), while the FY2026 annual figure was -$244000.0, down 144.36% from the prior year.
- Tax Provisions for Q1 2026 stood at $84000.0, up from -$130000.0 in the prior quarter.
- The five-year high for Tax Provisions was $471000.0 in Q1 2022, with the low at -$292000.0 in Q1 2024.
- The 5-year median for Tax Provisions is $9000.0 (2024), against an average of $32294.1.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions soared 1900.0% in 2022, then tumbled 1544.44% in 2025.
- Sonoma Pharmaceuticals' Tax Provisions stood at $34000.0 in 2022, then tumbled by 267.65% to -$57000.0 in 2023, then jumped by 115.79% to $9000.0 in 2024, then sank by 1544.44% to -$130000.0 in 2025, then soared by 164.62% to $84000.0 in 2026.
- Business Quant data shows SNOA's Tax Provisions at $84000.0 in Q1 2026, -$130000.0 in Q4 2025, and -$197000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84,000.00 |
| Dec 31, 2025 | -130,000.00 |
| Sep 30, 2025 | -197,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 248,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | -292,000.00 |
| Dec 31, 2023 | -57,000.00 |
| Sep 30, 2023 | 186,000.00 |
| Jun 30, 2023 | -33,000.00 |
| Mar 31, 2023 | -131,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | -35,000.00 |
| Mar 31, 2022 | 471,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 713,000.00 |
| Mar 31, 2018 | 50,000.00 |